Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q35159120)
Watch
English
Current anticoagulant therapy--unmet clinical needs
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
12818628
retrieved
6 August 2017
review article
1 reference
stated in
Europe PubMed Central
title
Current anticoagulant therapy--unmet clinical needs
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
12818628
retrieved
6 August 2017
main subject
anticoagulation
1 reference
based on heuristic
inferred from title
anticoagulant
1 reference
based on heuristic
inferred from title
author name string
Jack Hirsh
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
12818628
retrieved
6 August 2017
publication date
1 July 2003
1 reference
stated in
Europe PubMed Central
PubMed ID
12818628
retrieved
6 August 2017
published in
Thrombosis Research
1 reference
stated in
Europe PubMed Central
PubMed ID
12818628
retrieved
6 August 2017
volume
109 Suppl 1
1 reference
stated in
Europe PubMed Central
PubMed ID
12818628
retrieved
6 August 2017
page(s)
S1-8
1 reference
stated in
Europe PubMed Central
PubMed ID
12818628
retrieved
6 August 2017
cites work
Blood coagulation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Molecular and cellular biology of blood coagulation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Heparin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oral anticoagulant drugs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antithrombotic effects and bleeding time of thrombin inhibitors and warfarin in the rat
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The emerging role of low-molecular-weight heparin in cardiovascular medicine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Low-molecular-weight heparins
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: implications for heparin efficacy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Protection of factor Xa from neutralization by the heparin-antithrombin complex
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A synthetic factor-Xa inhibitor (ORG31540/SR9017A) as an adjunct to fibrinolysis in acute myocardial infarction. The PENTALYSE study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Heparinless cardiopulmonary bypass with active-site blocked factor IXa: a preliminary study on the dog.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Active site-blocked factor IXa prevents intravascular thrombus formation in the coronary vasculature without inhibiting extravascular coagulation in a canine thrombosis model
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antithrombotic efficacy of a novel murine antihuman factor IX antibody in rats.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy and safety of recombinant human activated protein C for severe sepsis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An update on clinical and basic aspects of the protein C anticoagulant pathway
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anticoagulant repertoire of the hookworm Ancylostoma caninum
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Thrombin binds to soluble fibrin degradation products where it is protected from inhibition by heparin-antithrombin but susceptible to inactivation by antithrombin-independent inhibitors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Kinetics of the inhibition of thrombin by hirudin.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New anticoagulant drugs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Use of recombinant hirudin as antithrombotic treatment in patients with heparin-induced thrombocytopenia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hirudin therapy for heparin-associated thrombocytopenia and deep venous thrombosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bivalirudin: a new generation antithrombotic drug
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical outcomes of bivalirudin for ischemic heart disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Novastan (brand of argatroban): a small-molecule, direct thrombin inhibitor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Soluble plasma thrombomodulin levels in patients with chronic myeloproliferative disorder
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Argatroban for prevention and treatment of thromboembolism in heparin-induced thrombocytopenia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Discovery and development of the novel potent orally active thrombin inhibitor N-(9-hydroxy-9-fluorenecarboxy)prolyl trans-4-aminocyclohexylmethyl amide (L-372,460): coapplication of structure-based design and rapid multiple analogue synthesis on so
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The direct thrombin inhibitor melagatran and its oral prodrug H 376/95: intestinal absorption properties, biochemical and pharmacodynamic effects
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetics and pharmacodynamics of ximelagatran, a novel oral direct thrombin inhibitor, in young healthy male subjects
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacokinetics, pharmacodynamics and clinical effects of the oral direct thrombin inhibitor ximelagatran in acute treatment of patients with pulmonary embolism and deep vein thrombosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Importance of factor Xa in determining the procoagulant activity of whole-blood clots
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The benefit-to-risk profile of melagatran is superior to that of hirudin in a rabbit arterial thrombosis prevention and bleeding model
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized, controlled, dose-guiding study of the oral direct thrombin inhibitor ximelagatran compared with standard therapy for the treatment of acute deep vein thrombosis: THRIVE I.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900250-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0049-3848(03)00250-0
1 reference
stated in
Europe PubMed Central
PubMed ID
12818628
retrieved
6 August 2017
PubMed ID
12818628
1 reference
stated in
Europe PubMed Central
PubMed ID
12818628
retrieved
6 August 2017
ResearchGate publication ID
10697163
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit